Cristian Massacesi, Executive Vice President, Chief Medical Officer and Head of Development, on September 09, 2026, sold 6,249 shares in Bristol Myers Squibb (BMY) for $403,498. Following the Form 4 filing with the SEC, Massacesi has control over a total of 18,748 common shares of the company, with 18,748 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/14272/000208017626000006/xslF345X05/wk-form4_1789072637.xml
Richard C Puccio Jr, Executive Vice President and CFO, on September 08, 2026, sold 1,500 shares in Analog Devices (ADI) for $545,475. Following the Form 4 filing with the SEC, Puccio has control over a total of 52,677 common shares of the company, with 52,677 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/6281/000200911026000007/xslF345X05/wk-form4_1788991040.xml
David A Duffield, 10% Owner, on September 04, 2026, sold 90,615 shares in Workday (WDAY) for $17,954,368. Following the Form 4 filing with the SEC, Duffield has control over a total of 105,049 Class A common shares of the company, with 105,049 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1327811/000093807126000051/xslF345X05/wk-form4_1788990725.xml
Eric H. L. So, Director, Executive Chair, on September 01, 2026, executed a purchase for 95,000 shares in Cybin (CYBN) for $1,121,475. Following the Form 4 filing with the SEC, So has control over a total of 4,318,630 common shares of the company, with 4,265,014 shares held directly and 53,616 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1833141/000091228226001254/xslF345X05/form4.xml